July 30, 2024 at 8:47 am

Stocks making the biggest moves premarket: CrowdStrike, Merck, PayPal, JetBlue and more

Here’s an update of companies making quite the buzz in premarket trading sessions. CrowdStrike experienced a 5% dip in share value as Delta Airlines procures legal support for damage claims against CrowdStrike and Microsoft following a software update mishap that disrupted numerous flights in July. Woodward, the aerospace and industrial equipment company experienced an over… [Read More]
July 29, 2024 at 5:23 pm

Ekso Bionics Reports Record Quarterly Sales of $5.0 Million in Second Quarter 2024

Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), a PRISM MedTech mover and industry leader in exoskeleton technology for medical and industrial use, today reported financial results for the three and six months ended June 30, 2024. Ekso Bionics achieved record quarterly sales of $5.0 million in the second quarter of 2024, reflecting strong growth and significant… [Read More]
July 29, 2024 at 5:13 pm

McDonald’s Earnings Fall Short, But Stock Rises on Optimism for Value Meals

McDonald’s (MCD) reported disappointing second-quarter earnings on Monday, with both profit and revenue falling short of expectations. Despite this, the fast-food giant’s stock rose 3.3% to $260.38, marking its best post-earnings performance in more than five years. The company’s adjusted earnings per share came in at $2.97, missing Wall Street’s estimate of $3.07, according to… [Read More]
July 29, 2024 at 10:20 am

Uranium Royalty (UROY) Acquires Additional Royalty Interest on One of Largest Undeveloped ISR Uranium Projects in US

PRISM New Energy Index company, Uranium Royalty Corp (UROY) has signed an agreement to acquire additional royalty interest in a portion of the Churchrock uranium project which is indirectly owned by Laramide Resources, Ltd. in New Mexico. This project and its nearby properties represents one of the largest and highest-grade undeveloped ISR uranium projects in… [Read More]
July 29, 2024 at 9:03 am

Phase 2a Initiated: Lipella (LIPO) Enrolls First Patients for LP-310 in Oral Lichen Planus

The clinical stage biotechnology company who is addressing serious diseases with significant unmet need, Lipella Pharmaceuticals (LIPO) has enrolled its first patient in its multi-center Phase 2a clinical trial. The company’s stock has risen over 200% today in premarket trading on the announcement. This trial will be evaluating Lipella’s oral rinse LP-310 which treats Oral… [Read More]
July 26, 2024 at 5:11 pm

The Dow Closes Powerfully Amid A Rough Week for Tech. Minor-Caps Impress.

On Friday, the Dow bounced back with zest after newly released data demonstrated effective control of inflation rates by the Federal Reserve. The Dow Jones Industrial Average surged by 654 points, a leap of 1.6%. Concurrently, the S&P 500 and the Nasdaq Composite made an upward move by 1.1% and 1% respectively, partly compensating for… [Read More]
July 26, 2024 at 1:18 pm

What Was American Airlines Thinking? Additional Airline Earnings Echo Previous Industry Trends as Southwest Assigns Seats.

Last week, PRISM took the temperature of the traveling consumer as airlines began to announce their financial results. Further company reports this week have echoed larger themes related to higher fuel costs, robust travel demand and lower fare discounting driven by competition from low-cost carriers. Notably, American Airlines (AAL) had an additional citing specific to… [Read More]
July 25, 2024 at 1:39 pm

Psyence (PBM) Goes Down Under with Export of Psilocybin to Australia While Phase 2b Study Progresses

The PRISM Psychedelics Index leader Psyence Biomedical Ltd. (PBM) is up over 50% today on the announcement regarding its successful export of nature-derived psilocybin to Australia and has provided an update on its forthcoming Phase 2b clinical trial. This trial will evaluate nature-derived psilocybin as a potential treatment for Adjustment Disorder following an advanced cancer… [Read More]